“We are proud to have hosted 35 on-to-one meetings between companies and investors in today’s partnering sessions” says Hanne Mette Dyrlie Kristensen, CEO at The Life Science Cluster. Close to 90 attendees watched the Investor partnering webinar and got advice from investors on how to prepare for investor follow-up meetings.
You may view the webinar recordings here if you missed out on our 2nd annual Life Science Investor partnering webinar 18 March.
After the first meeting
Øyvind Enger, at Sarsia Seed, started the seminar with a guide through all steps of the investor process, aimed at start-ups looking for early investments, including the first investment in a company.
During the seminar, several Norwegian investors presented themselves and gave valuable advice on how to follow up and be prepared to meet the investor again after you have managed to attract the first interest.
Maren Hjorth Bauer, Managing Partner and Founder at Fynd Ocean Ventures emphasised their active role in supporting companies hands on. Ingrid Teigland Akay, Managing Partner at Hadean Ventures presented their strategy and why they are investing in the health sector with a particular focus on the Nordic region. Birgitte Gangmark Villmo, Senior Associate at Investinor ended the investor presentations with an overview of the changes at Investinor, meaning that they now invest both in funds and directly in companies.
Reflections from an early-stage biotech company
Jonas Hallén, Chief Medical Officer and Co-Founder of Arxx Therapeutics gave a description on their process of getting financing as a start-up. He especially underlined the importance of managing your risks and being persistent.
An international take on the investor process
Back Bay Life Science, also a member of the Life Science Cluster, gave an international view on the investor process and along with highlighting the difference between the Nordics and the US. With us from Boston was Jonathan Gertler, Co-Founder, Managing Partner and CEO, along with his colleague Vasilios Kofitsas.
What if it does not work out?
The speakers were broadly unanimous in their advice on how to tackle a rejection: Stay polite and get as much advice as you can before leaving. Chances are you will meet the same investor again further down the road.
Due Diligence and Patenting
Tord Fondevik, partner at Schjødt and Aase Gundersen, Special Counsel at SANDS, shared their insight and knowledge on the due diligence process and the importance of patenting. Nils Rynning Mork from Admincontrol presented their valuable data room tool for dealing with the complexities of the due diligence process.
Admincontrol, Bayer and Back Bay Life Science Advisors were also valued sponsors of the event.